OpenEvidence
74
Quality Score
Strong
OpenEvidence
Medium confidence
✍️ bumetric analysis
“
OpenEvidence is an iOS app from OpenEvidence Inc. in the Medical category, currently rated 4.9★ across 9,715 ratings. Initial signal reads as mixed reviews: supporters praise core features while critics cite stability and value gaps.
Quality Score is 74: Strong (healthy traction). For a Medical app, that means healthy traction. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
💰 Monthly revenue · now vs forecast
● Right now
$1.0K
per month
→
12-mo forecast
$903 – $3254
per month
→
24-mo forecast
$836 – $7528
per month
INDIE tier
💡 Grow this revenue
Free AI audit of this app’s store listing
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
Typical impact: +2-5× organic installs
📊 Performance Tracking LIVE
Loading…
Rating
—
Reviews
—
Forecast Revenue / mo
—
Snapshots tracked
0
since first record
ONE-TIME · BUILD
💰 Estimated build cost
$105K
↳ What it cost to build · not monthly revenue
Likely range $80K – $140K
$25K · MVP floor
$100K · indie scale
$500K+ · studio build
📈
Slow ROI — current MRR is well below build cost
Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
Where the money goes
| 🧱 MVP baseline (design + 1-store ship) | +$28K |
| 📱 5 unique screens × $4.5K | +$22K |
| 📦 Asset bundle (90 MB) | +$16K |
| ⚙ Medical complexity ×1.55 | +$36K |
Total estimate
$105K
ONE-TIME · EXIT VALUE
💵 Estimated acquisition value
$20K
↳ What it would sell for · not monthly revenue
Marketplace range $15K – $25K · 19× MRR multiple
💸
~0.2× build cost (under-water)
Synthetic estimate. Multiple band derived from ad-supported + age, rating quality, category demand, and user-base maturity. Calibrated against 2024-2026 indie-app-marketplace closed-deal medians. Full math + comparable deal list on /methodology.
How the multiple was built
| 📺 Ad-supported base | 15× MRR |
| ⭐ ★ rating ≥ 4.7 (premium) | +15% |
| 🏷 Medical category multiple | +12% |
Final multiple
19× MRR
👥 Estimated audience size
530K
Lifetime downloads (US-equivalent)
Monthly active
130K
Daily active
26K
Synthetic estimate from ratings × category benchmarks. Calibrated against 2024-2026 mobile-attribution retention + DAU/MAU reports. Numbers are US-storefront-equivalent — true global audience can be 5-10× larger for international apps. Full math + source list on /methodology.
How we sized it
| 📲 Medical engagement | ~55 installs / rating |
| 🔁 Medical D30 retention | 25% |
| 📍 DAU / MAU stickiness | 0.20 |
DAU / MAU
20% sticky
🔬
How we forecast this revenue
MEDIUM CONFIDENCEBaseline
$1.0K/mo · ML-estimated from 234 triggers
Growth rate
+6.0% MoM · INDIE tier baseline (compound monthly)
Direction
Headwinds: low defensibility moat
6 months
$879 – $2.1K
12 months
$903 – $3.3K
24 months
$836 – $7.5K
Compound growth at +6.0% MoM (tier baseline for INDIE). Range widens with horizon — typical noise band ±40% at 6mo.. Ranges widen with horizon — distant futures carry more uncertainty.
📊
BU Investment Matrix
Early-stage solo · 42/100INDIE TIERexpected for tierGrowth Velocity
5.0
Founder Strength
3.0
Product Quality
8.9
Revenue Strength
3.0
Monetization Maturity
1.0
Defensibility
2.5
Market Position
0.6
Operational Safety
10.0
- 💰 Revenue: Modest — $413 - $2582/mo · INDIE tier · medium confidence, trajectory unclear.
- ⭐ Quality: 4.92★ across 9,715 reviews — strong (top 10%).
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: dev shipping weekly.
- ⚠️ Risk: Low — no material risk signals detected.
🎯 For competitors: Mixed picture. Worth competing if you have a clear UX or pricing edge — otherwise crowded segment.
💵 For acquirers: Estimated asking range 18-32× monthly = $18K-$33K.
Composite of 8 dimensions computed deterministically from public signals — no LLM, every score traces back to a measurable input. Default weights shown; "compete" / "acquire" / "invest" lenses re-weight without re-fetching.
Range:
💰 Forecast Revenue / mo
MODELRevenue forecast computed from BU's 234 trigger model on each snapshot. Calibrated against ground-truth from 58 verified-revenue apps.
🔬Forecast Breakdown — Why This Estimate?Top 11 of 11 triggers
Our ML model uses 200+ signals from public data. These are the most influential for this app:
| Excellent rating (4.9★)METRIC | +$2,200 | |
| frequent crashesREVIEW | −$2,000 | |
| excellent appREVIEW | +$1,500 | |
| Low install base (9,715 ratings)METRIC | +$1,500 | |
| highly recommendREVIEW | +$1,400 | |
| slowREVIEW | −$1,200 | |
| too expensiveREVIEW | −$1,000 | |
| support teamREVIEW | +$900 | |
| Ad-supported / freemiumMETRIC | +$600 | |
| Single-language (English only)METRIC | −$400 | |
| Growing app (1y old)METRIC | +$200 |
METRIC = structural app data · REVIEW = mined from user reviews · ✓ VERIFIED = Stripe-verified anchor (TrustMRR)
📈 Reviews Growth
LIVECumulative review count from first BU snapshot. Each point = a tracked update.
⭐ Rating Trend
LIVEAverage rating evolution. Updates with each new review batch.
🆕 What's New · v2.9.11
* NEJM, JAMA, and NCCN content partnership
* Streamlined experience during answer writing
* Performance enhancements
* Streamlined experience during answer writing
* Performance enhancements
Profile & Insights
Everything we know — and don't — about this app and its company.
Identification
- App name
- OpenEvidence
- Developer
- OpenEvidence Inc.
- Bundle ID
- com.openevidence
- App Store URL
- Open in App Store
- Category
- Medical
- Content rating
- 17+
- Languages
- EN
Company
- Website
- Not found
- Tagline
- OpenEvidence is not available in the European Union or the U.K.
- Description
- America's Official Medical Knowledge Platform. OpenEvidence is the leading medical platform for healthcare professionals, featuring answers grounded in peer-reviewed research from NEJM, JAMA, NCCN, Cochrane, and more.
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Available
Revenue
- Verified revenue / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- ML model estimate / mo
- $1.0K/mo
- Top-grossing rank
- Outside top 100 in US Medical
- All-time revenue
- Not found
- Pricing
- Not found
Founder
Founder data not yet collected for this app.
Funding
Funding data not yet collected for this app.
Press & Links
Press & Links data not yet collected for this app.
Contacts & Socials
Contacts & Socials data not yet collected for this app.
📈Ratings growth10,348 ratings+1864% lifetimeShow 3-year history estimate ▾
Tracked (55 weeks) Pre-tracking estimate (22 weeks) · model-based, ±5% noise · anchored to release date and current value
🌍Geographic ReachNot ranked
This app is currently outside the top 100 grossing in all 9 countries we monitor (US, UK, DE, FR, JP, CA, AU, BR, IN). Niche or new apps often launch this way — popularity rankings appear once daily revenue clears the regional threshold.
🚀Version Release Timeline2 releases tracked
Profile is built from iTunes Lookup + developer site scrape + ML revenue model. Empty fields show "Not found" — additional sources (Crunchbase, X, IndieHackers, Acquire.com) coming.
📝 About this app
Clinical Decision Support & Medical Search Engine for Healthcare Professionals (NPI Required).
OpenEvidence is trusted by hundreds of thousands of verified healthcare professionals to support high-stakes clinical decisions at the point of care with answers that are sourced, cited, and grounded in peer-reviewed medical literature.
OpenEvidence is the fastest-growing and most widely-used clinical decision support platform in the world–used daily, on average, by over 40% of physicians in the United States, spanning more than 10,000 hospitals and medical centers nationwide.… View full description on the official store →
OpenEvidence is trusted by hundreds of thousands of verified healthcare professionals to support high-stakes clinical decisions at the point of care with answers that are sourced, cited, and grounded in peer-reviewed medical literature.
OpenEvidence is the fastest-growing and most widely-used clinical decision support platform in the world–used daily, on average, by over 40% of physicians in the United States, spanning more than 10,000 hospitals and medical centers nationwide.… View full description on the official store →
App Specs
🔐 Own this app? Claim & verify MRR →💾 90 MB🔞 17+📱 iOS 15.1+🔖 v2.9.11🔄 updated 0d ago🌐 EN📂 Medical💰 Free
📅
What Worked™ · Development Pipeline
7 EVENTS TRACKEDDetected changes in this app over its tracked lifetime — each event links cause (what changed) to effect (what moved). Sorted newest first.See full history →Version history →
2026-05
🔄
Monetization changed: freemium → free
2026-03
⭐
Rating ↑ 4.30 → 4.80 (improved 0.50★)
2026-03
📈
Crossed 500 ratings — social-proof flywheel kicking in
2025-07
📈
Crossed 100 ratings — social-proof flywheel kicking in
2025-02
📈
Crossed 50 ratings — social-proof flywheel kicking in
2024-09
📈
Crossed 10 ratings — social-proof flywheel kicking in
2024-08
🚀
First tracked snapshot — initial data captured
🌍
Multi-Country Performance
Available in 2 of 9 monitored markets| Market | Rating | Reviews | Current version |
|---|---|---|---|
| 🇨🇦 CA | 4.90895★ | 659 | 4.90895★ this version |
| 🇺🇸 US | 4.92269★ | 10,348 | 4.92269★ this version |
🔔
Track this app’s revenue
FREEGet an email when revenue moves by your threshold. No spam, unsubscribe in one click.
📝 Description
95
BU Score · Transcendent
Full revenue analysis
Read the article-style breakdown for OpenEvidence: category rank, percentile, growth signal, comparable apps, and how the forecast is calibrated against verified-MRR anchors in this niche.
About this analysis
Why medium confidence: 9,715 ratings · no founder-verified revenue (model estimate only).
❓ Frequently Asked Questions
4 answers · auto-generated from this app's public dataHow much does OpenEvidence make per month?▴
Based on our ML-calibrated revenue forecast, OpenEvidence earns approximately $1.0K/mo. This is a US-storefront-equivalent estimate; global revenue can be several times larger for internationally-distributed apps. See the methodology page for the full formula and confidence bands.
What apps are like OpenEvidence?▴
Browse the full Medical category catalog to find similar apps with revenue, build cost, audience and tech stack data. Each /p/{slug} page also shows a Compare side-by-side widget with three peer apps from the same niche.
Who makes OpenEvidence?▴
OpenEvidence is published by OpenEvidence Inc. on the Apple App Store. See the full publisher portfolio (other apps by the same developer) via the More by developer block on the product page above.
What is OpenEvidence's BU Score?▴
OpenEvidence has a BU Score of 74/100 (Strong). The score combines App Store rating, ratings count, monetization model and revenue signals calibrated against founder-verified MRR anchors. See the BU Score formula.